139 related articles for article (PubMed ID: 3460164)
21. Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection.
Ohning GV; Barbuti RC; Kovacs TO; Sytnik B; Humphries TJ; Walsh JH
Aliment Pharmacol Ther; 2000 Jun; 14(6):701-8. PubMed ID: 10848652
[TBL] [Abstract][Full Text] [Related]
22. Pharmacology and toxicology of omeprazole--with special reference to the effects on the gastric mucosa.
Carlsson E; Larsson H; Mattsson H; Ryberg B; Sundell G
Scand J Gastroenterol Suppl; 1986; 118():31-8. PubMed ID: 3460170
[TBL] [Abstract][Full Text] [Related]
23. Effects of omeprazole, a substituted benzimidazole, on gastrointestinal secretions, serum gastrin, and gastric mucosal blood flow in dogs.
Konturek SJ; Cieszkowski M; Kwiecień N; Konturek J; Tasler J; Bilski J
Gastroenterology; 1984 Jan; 86(1):71-7. PubMed ID: 6689674
[TBL] [Abstract][Full Text] [Related]
24. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W
Digestion; 1995; 56(2):137-44. PubMed ID: 7750667
[TBL] [Abstract][Full Text] [Related]
25. The effect of omeprazole on insulin induced gastric secretion in man.
Utley RJ; Wright R; Beastall GH; Carter DC
Scott Med J; 1985 Apr; 30(2):96-100. PubMed ID: 3892679
[TBL] [Abstract][Full Text] [Related]
26. Effect of omeprazole on the secretion of intrinsic factor, gastric acid and pepsin in man.
Kittang E; Aadland E; Schjønsby H
Gut; 1985 Jun; 26(6):594-8. PubMed ID: 3924748
[TBL] [Abstract][Full Text] [Related]
27. Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release.
Londong W; Londong V; Cederberg C; Steffen H
Gastroenterology; 1983 Dec; 85(6):1373-8. PubMed ID: 6354828
[TBL] [Abstract][Full Text] [Related]
28. Omeprazole-induced hypergastrinemia: role of gastric acidity.
Larson GM; Sullivan HW; Rayford P
J Surg Res; 1986 May; 40(5):504-9. PubMed ID: 3736035
[TBL] [Abstract][Full Text] [Related]
29. Omeprazole, a long-lasting inhibitor of gastric secretion.
Larson GM; Sullivan HW
J Surg Res; 1984 May; 36(5):503-7. PubMed ID: 6727328
[TBL] [Abstract][Full Text] [Related]
30. Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment.
Lind T; Cederberg C; Forssell H; Olausson M; Olbe L
Scand J Gastroenterol; 1988 Dec; 23(10):1259-66. PubMed ID: 3249924
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
Pratha VS; Hogan DL; Lane JR; Williams PJ; Burton MS; Lynn RB; Karlstadt RG
Dig Dis Sci; 2006 Jan; 51(1):123-31. PubMed ID: 16416224
[TBL] [Abstract][Full Text] [Related]
32. Omeprazole inhibition of nocturnal gastric secretion in patients with duodenal ulcer.
Hetzel DJ; Shearman DJ
Br J Clin Pharmacol; 1984 Oct; 18(4):587-90. PubMed ID: 6487498
[TBL] [Abstract][Full Text] [Related]
33. Prolonged inhibition of acid secretion causes hypergastrinaemia without altering pH inhibition of gastrin release in humans.
Karnes WE; Berlin RG; Maxwell V; Sytnik B; Root JK; Walsh JH
Aliment Pharmacol Ther; 1990 Oct; 4(5):443-56. PubMed ID: 2129633
[TBL] [Abstract][Full Text] [Related]
34. Effect of intermittent weekend therapy with omeprazole on basal and bombesin- and pentagastrin-stimulated gastric acid and serum gastrin.
Crobach LF; Jansen JB; Lamers CB
Scand J Gastroenterol; 1988 May; 23(4):407-12. PubMed ID: 3381063
[TBL] [Abstract][Full Text] [Related]
35. Basal, sham feed and pentagastrin stimulated gastric acid, pepsin and electrolytes after omeprazole 20 mg and 40 mg daily.
Thompson JN; Barr JA; Collier N; Spencer J; Bush A; Cope L; Gribble RJ; Baron JH
Gut; 1985 Oct; 26(10):1018-24. PubMed ID: 3932137
[TBL] [Abstract][Full Text] [Related]
36. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.
Dammann HG; Burkhardt F
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1277-82. PubMed ID: 10563540
[TBL] [Abstract][Full Text] [Related]
37. Effect of repeated oral administration of BY 1023/SK&F 96022--a new substituted benzimidazole derivative--on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
Simon B; Müller P; Marinis E; Lühmann R; Huber R; Hartmann R; Wurst W
Aliment Pharmacol Ther; 1990 Aug; 4(4):373-9. PubMed ID: 2151747
[TBL] [Abstract][Full Text] [Related]
38. Omeprazole in elderly duodenal ulcer patients: relationship between reduction in gastric acid secretion and fasting plasma gastrin.
Lind T; Cederberg C; Olausson M; Olbe L
Eur J Clin Pharmacol; 1991; 40(6):557-60. PubMed ID: 1884735
[TBL] [Abstract][Full Text] [Related]
39. Weekend treatment with 20 and 40 mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens.
Baak LC; Jansen JB; Biemond I; Lamers CB
Gut; 1991 Sep; 32(9):977-82. PubMed ID: 1916501
[TBL] [Abstract][Full Text] [Related]
40. Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion.
Biemond I; Crobach LF; Jansen JB; Lamers CB
Eur J Clin Pharmacol; 1989; 37(4):345-9. PubMed ID: 2598968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
